Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-05-20

FDA Approved: PRIMIDONE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for PRIMIDONE from Lannett Company, Inc., a generic antiseizure medication. The action is linked to ANDA084903.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRIMIDONE (Primidone)

Snippet

SUPPL AP for PRIMIDONE (PRIMIDONE)